1. Home
  2. SXI vs ZLAB Comparison

SXI vs ZLAB Comparison

Compare SXI & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXI
  • ZLAB
  • Stock Information
  • Founded
  • SXI 1955
  • ZLAB 2013
  • Country
  • SXI United States
  • ZLAB China
  • Employees
  • SXI N/A
  • ZLAB N/A
  • Industry
  • SXI Industrial Machinery/Components
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SXI Industrials
  • ZLAB Health Care
  • Exchange
  • SXI Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • SXI 2.5B
  • ZLAB 3.0B
  • IPO Year
  • SXI N/A
  • ZLAB 2017
  • Fundamental
  • Price
  • SXI $202.71
  • ZLAB $27.38
  • Analyst Decision
  • SXI Strong Buy
  • ZLAB Strong Buy
  • Analyst Count
  • SXI 3
  • ZLAB 4
  • Target Price
  • SXI $227.00
  • ZLAB $52.50
  • AVG Volume (30 Days)
  • SXI 44.3K
  • ZLAB 1.2M
  • Earning Date
  • SXI 10-29-2024
  • ZLAB 11-12-2024
  • Dividend Yield
  • SXI 0.63%
  • ZLAB N/A
  • EPS Growth
  • SXI N/A
  • ZLAB N/A
  • EPS
  • SXI 6.09
  • ZLAB N/A
  • Revenue
  • SXI $706,325,000.00
  • ZLAB $355,748,000.00
  • Revenue This Year
  • SXI $10.69
  • ZLAB $48.50
  • Revenue Next Year
  • SXI $7.69
  • ZLAB $47.37
  • P/E Ratio
  • SXI $33.00
  • ZLAB N/A
  • Revenue Growth
  • SXI N/A
  • ZLAB 35.01
  • 52 Week Low
  • SXI $131.96
  • ZLAB $13.48
  • 52 Week High
  • SXI $211.90
  • ZLAB $36.60
  • Technical
  • Relative Strength Index (RSI)
  • SXI 66.16
  • ZLAB 49.37
  • Support Level
  • SXI $201.28
  • ZLAB $26.47
  • Resistance Level
  • SXI $211.90
  • ZLAB $32.15
  • Average True Range (ATR)
  • SXI 5.93
  • ZLAB 1.36
  • MACD
  • SXI 1.48
  • ZLAB -0.64
  • Stochastic Oscillator
  • SXI 83.29
  • ZLAB 30.81

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Share on Social Networks: